Results 201 to 210 of about 713,550 (341)

Geographic variability in outcomes within an international trial of glycoprotein IIb/IIIa inhibition in patients with acute coronary syndromes. Results from PURSUIT [PDF]

, 2000
K. Martijn Akkerhuis
openalex   +1 more source

Commonalities of platelet dysfunction in heart failure with preserved ejection fraction and underlying comorbidities

ESC Heart Failure, Volume 12, Issue 2, Page 1013-1028, April 2025.
Abstract Heart failure with preserved ejection fraction (HFpEF) is characterized by a lack of a specific targeted treatment and a complex, partially unexplored pathophysiology. Common comorbidities associated with HFpEF are hypertension, atrial fibrillation, obesity and diabetes.
Giorgia D'Italia, Blanche Schroen, Judith M.E.M. Cosemans   +2 more
wiley   +1 more source

Circulating mitochondrial biomarkers in acute coronary syndrome. [PDF]

Front Med (Lausanne)
Iboleon-Jimenez A, Sánchez-Quintero MJ, Carmona-Segovia ADM, Sojo B, Fernández-Ramos AM, García-Rodríguez L, Molina-Ramos AI, García-Pinilla JM, Jimenez-Navarro M, Ortega-Gomez A.   +9 more
europepmc   +1 more source

Prevalence and outcome of patients with cancer and acute coronary syndrome undergoing percutaneous coronary intervention: a BleeMACS substudy

European heart journal. Acute cardiovascular care, 2018
M. Iannaccone, F. D’Ascenzo, P. Vadalà, S. Wilton, P. Noussan, F. Colombo, S. Raposeiras Roubín, E. Abu Assi, J. González-Juanatey, J. P. Simao Henriques, J. Saucedo, W. Kikkert, I. Nuñez-Gil, A. Ariza-Solé, Xiantao Song, D. Alexopoulos, C. Liebetrau, Tetsuma Kawaji, C. Moretti, R. Garbo, Z. Huczek, S. Nie, Toshiharu Fujii, L. Correia, M. Kawashiri, J. M. Garcia Acuña, D. Southern, Emilio Alfonso, B. Terol, A. Garay, Dongfeng Zhang, Yalei Chen, I. Xanthopoulou, N. Osman, H. Möllmann, H. Shiomi, F. Giordana, M. Kowara, K. Filipiak, Xiao Wang, Yan Yan, Jing-yao Fan, Y. Ikari, T. Nakahashi, K. Sakata, F. Gaita, M. Yamagishi, O. Kalpak, S. Kedev   +48 more
semanticscholar   +1 more source

The Role of Plaque Rupture in the Development of Acute Coronary Syndrome Evaluated by the Coronary Angioscope.

, 2000
Kazuhisa Kodama, Masanori Asakura, Yasunori Ueda, Osamu Yamaguchi, Atsushi Hirayama   +4 more
openalex   +1 more source

High Prevalence of Seropositivity for Antibodies toChlamydia-Specific Lipopolysaccharide in Patients with Acute Coronary Syndrome [PDF]

, 2000
Kazunori Shimada, Hiroshi Mokuno, Yoshirô Watanabe, Masato Sawano, Hiroyuki Daida, Hiroshi Yamaguchi   +5 more
openalex   +1 more source

The effects of sodium–glucose cotransporter 2 inhibitors on the ‘forgotten’ right ventricle

ESC Heart Failure, Volume 12, Issue 2, Page 1045-1058, April 2025.
Abstract With the progress in diagnosis, treatment and imaging techniques, there is a growing recognition that impaired right ventricular (RV) function profoundly affects the prognosis of patients with heart failure (HF), irrespective of their left ventricular ejection fraction (LVEF).
Liangzhen Qu, Xueting Duan, Han Chen
wiley   +1 more source

The Diagnosis and Prognosis Value of Exosomal MascRNA in Patients with Acute Coronary Syndrome. [PDF]

Int J Gen Med
Hou J, Weng R, Gu X, Zhao J, Li X, Liu S.   +5 more
europepmc   +1 more source

Benefit of switching dual antiplatelet therapy after acute coronary syndrome: the TOPIC (timing of platelet inhibition after acute coronary syndrome) randomized study

European Heart Journal, 2017
T. Cuisset, P. Deharo, J. Quilici, T. Johnson, S. Deffarges, C. Bassez, G. Bonnet, L. Fourcade, J. Mouret, M. Lambert, V. Verdier, P. Morange, M. Alessi, J. Bonnet   +13 more
semanticscholar   +1 more source

Safety and preliminary efficacy of one month glycoprotein IIb/IIIa inhibition with lefradafiban in patients with acute coronary syndromes without ST-elevation A phase II study [PDF]

, 2000
K. Martijn Akkerhuis
openalex   +1 more source